These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12669471)

  • 1. Anti-interferon-gamma antibodies in the treatment of autoimmune diseases.
    Skurkovich B; Skurkovich S
    Curr Opin Mol Ther; 2003 Feb; 5(1):52-7. PubMed ID: 12669471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of IFN-gamma as a method of treatment of various autoimmune diseases, including skin diseases.
    Skurkovich B; Skurkovich S
    Ernst Schering Res Found Workshop; 2006; (56):1-27. PubMed ID: 16329644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticytokine therapy, especially anti-interferon-gamma, as a pathogenetic treatment in TH-1 autoimmune diseases.
    Skurkovich S; Skurkovich B
    Ann N Y Acad Sci; 2005 Jun; 1051():684-700. PubMed ID: 16127009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticytokine therapy, particularly anti-IFN-gamma, in Th1-mediated autoimmune diseases.
    Skurkovich S; Skurkovich B; Kelly J
    Expert Rev Clin Immunol; 2005 May; 1(1):11-25. PubMed ID: 20477651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of IFN-gamma in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis.
    Matthys P; Vermeire K; Heremans H; Billiau A
    J Leukoc Biol; 2000 Oct; 68(4):447-54. PubMed ID: 11037964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferons as immunoregulatory molecules; implications for therapy in experimental autoimmune uveoretinitis.
    Mizuguchi J; Takeuchi M; Usui M
    Arch Immunol Ther Exp (Warsz); 2002; 50(4):243-54. PubMed ID: 12371620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune diseases are connected with disturbances in cytokine synthesis, and therapy with IFN-gamma blockers is their main pathogenetic treatment.
    Skurkovich B; Skurkovich S
    Ann N Y Acad Sci; 2007 Aug; 1109():167-77. PubMed ID: 17785303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neutralisation of interferon gamma--a new trend in therapy of rheumatoid arthritis].
    Nasonova VA; Lukina GV; Sigidin IaA
    Ter Arkh; 2008; 80(5):30-7. PubMed ID: 18590111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-gamma-deficient mice are resistant to the development of alopecia areata.
    Freyschmidt-Paul P; McElwee KJ; Hoffmann R; Sundberg JP; Vitacolonna M; Kissling S; Zöller M
    Br J Dermatol; 2006 Sep; 155(3):515-21. PubMed ID: 16911275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How interferon-gamma keeps autoimmune diseases in check.
    Kelchtermans H; Billiau A; Matthys P
    Trends Immunol; 2008 Oct; 29(10):479-86. PubMed ID: 18775671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cetirizine and allopurinol as novel weapons against cellular autoimmune disorders.
    Namazi MR
    Int Immunopharmacol; 2004 Mar; 4(3):349-53. PubMed ID: 15037212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticytokine therapy--new approach to the treatment of autoimmune and cytokine-disturbance diseases.
    Skurkovich SV; Skurkovich B; Kelly JA
    Med Hypotheses; 2002 Dec; 59(6):770-80. PubMed ID: 12445524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model.
    Sakurai F; Terada T; Maruyama M; Watanabe Y; Yamashita F; Takakura Y; Hashida M
    Cancer Gene Ther; 2003 Sep; 10(9):661-8. PubMed ID: 12944985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-gamma interferon (IFN-gamma) monoclonal antibodies.
    Bach JF
    Immunol Ser; 1993; 59():319-28. PubMed ID: 8461396
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis.
    Ansari NA; Ramesh V; Salotra P
    J Infect Dis; 2006 Oct; 194(7):958-65. PubMed ID: 16960784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma.
    Dajotoy T; Andersson P; Bjartell A; Löfdahl CG; Tapper H; Egesten A
    J Leukoc Biol; 2004 Sep; 76(3):685-91. PubMed ID: 15197236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of interferon gamma in regulation of CD4+ T-cells and its clinical implications.
    Chen J; Liu X
    Cell Immunol; 2009; 254(2):85-90. PubMed ID: 18848698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of catecholamines to shift T-cell cytokine responses toward a Th2 profile in patients with rheumatoid arthritis.
    Wahle M; Hanefeld G; Brunn S; Straub RH; Wagner U; Krause A; Häntzschel H; Baerwald CG
    Arthritis Res Ther; 2006; 8(5):R138. PubMed ID: 16889669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.